Parameter | Overall survival | Disease-free survival | ||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | P value | Hazard ratio | 95% CI | P value | |
AUF1 (fibroblasts) | 0.950 | 0.334–0.950 | 0.0315 | 0.634 | 0.634–0.426 | 0.0249 |
Tumor size | ||||||
T3 | 1.112 | 0.374–3.308 | 0.8480 | 0.403 | 0.174–0.931 | 0.0333 |
T4 | 0.756 | 0.160–3.578 | 0.7242 | 0.711 | 0.202–2.500 | 0.5952 |
Age (> 50 years) | 1.059 | 0.609–1.840 | 0.8392 | 0.2040 | 0.489–1.165 | 0.755 |
Stage | ||||||
IIIA | 1.934 | 0.534–6.997 | 0.3148 | 4.827 | 1.856–12.550 | 0.0012 |
IIIB | 3.237 | 0.589–17.782 | 0.1765 | 3.789 | 0.970–14.796 | 0.0553 |
Grade | ||||||
G2 | 0.649 | 0.097–6.172 | 0.8100 | 0.641 | 0.150–2.738 | 0.5483 |
G3 | 0.775 | 0.050–5.410 | 0.5862 | 0.743 | 0.172–3.215 | 0.6907 |
Lymph node | ||||||
N1 | 0.855 | 0.283–2.589 | 0.7821 | 0.661 | 0.310–1.406 | 0.2823 |
N2 | 1.515 | 0.447–5.132 | 0.5049 | 0.890 | 0.387–2.048 | 0.7848 |
N3 | 0.923 | 0.206–4.135 | 0.9162 | 0.623 | 0.217–1.785 | 0.3782 |
HR_ Status | ||||||
ER(+ve)/Her2(−ve) | 0.433 | 0.182–1.030 | 0.0584 | 0.502 | 0.502–0.275 | 0.0249 |
ER(−ve)/Her2(+ve) | 1.353 | 0.714–2.564 | 0.3536 | 1.045 | 1.045–0.643 | 0.8594 |
ER(−ve)/Her2(−ve) | 1.113 | 0.584–2.123 | 0.7448 | 1.013 | 1.013–2.231 | 0.9586 |
AUF1 (cancer cells) | 1.042 | 0.629–1.726 | 0.8742 | 0.937 | 0.646–1.359 | 0.7305 |
Tumor size | ||||||
T3 | 1.148 | 0.380–3.468 | 0.8071 | 0.427 | 0.182–1.001 | 0.0504 |
T4 | 0.665 | 0.136–3.259 | 0.6150 | 0.736 | 0.202–2.681 | 0.6415 |
Age (> 50 years) | 1.034 | 0.594–1.801 | 0.9051 | 0.734 | 0.475–1.134 | 0.1639 |
Stage | ||||||
IIIA | 1.733 | 0.476–6.309 | 0.4041 | 4.327 | 1.652–11,335 | 0.0029 |
IIIB | 3.585 | 0.629–20.426 | 0.1505 | 3.573 | 0.884–14.443 | 0.0740 |
Grade | ||||||
G2 | 0.716 | 0.091–5.651 | 0.7515 | 0.676 | 0.158–2.892 | 0.5977 |
G3 | 0.915 | 0.115–7.288 | 0.9330 | 0.818 | 0.189–3.546 | 0.7883 |
Lymph node | ||||||
N1 | 0.897 | 0.298–2.703 | 0.8467 | 0.701 | 0.330–1.488 | 0.3542 |
N2 | 1.664 | 0.498–5.552 | 0.4078 | 0.976 | 0.428–2.226 | 0.9539 |
N3 | 0.922 | 0.201–4.232 | 0.9167 | 0.668 | 0.232–1.925 | 0.4551 |
HR_ Status | ||||||
ER(+ve)/Her2(−ve) | 0.466 | 0.196–1.104 | 0.0828 | 0.531 | 0.292–0.969 | 0.0390 |
ER(−ve)/Her2(+ve) | 1.444 | 0.763–2.731 | 0.2590 | 1.089 | 0.670–1.768 | 0.7317 |
ER(−ve)/Her2(−ve) | 1.162 | 0.608–2.220 | 0.6503 | 1.060 | 0.658–1.709 | 0.8104 |